Obsidian Therapeutics Announces $49.5 Million Series A Financing … – Business Wire (press release)
FierceBiotech |
Obsidian Therapeutics Announces $49.5 Million Series A Financing …
Business Wire (press release) CAMBRIDGE, Mass.–(BUSINESS WIRE)–Obsidian Therapeutics, Inc., a biotechnology company dedicated to the development of next-generation cell and gene therapies with pharmacologic operating systems, today announced the completion of a $49.5 million … Looking for the next big breakthrough in CAR-T, Mike Gilman debuts … |
